FLOW, a Kidney Outcomes Trial of Semaglutide in T2D and CKD FLOW, a Kidney Outcomes Trial of Semaglutide in T2D and CKD
What have we learned from the FLOW trial about the effects of semaglutide among people with type 2 diabetes and chronic kidney disease?Nephrology Dialysis Transplantation
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news
More News: Chronic Kidney Disease | Diabetes | Diabetes Type 2 | Dialysis | Endocrinology | Health | Kidney Transplant | Kidney Transplantation | Transplants | Urology & Nephrology